Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function.
about
A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcriptionCA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcriptionPITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes.Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodiesThe HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase IIThe human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzymeMolecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domainLentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactorThe human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for functionPhosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcriptionTat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcriptionTranscription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitroP-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase IIRabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infectionHuman GLI-2 is a tat activation response element-independent Tat cofactor.Ubiquitylation of Cdk9 by Skp2 facilitates optimal Tat transactivation.Utilization of a mammalian cell-based RNA binding assay to characterize the RNA binding properties of picornavirus 3C proteinases.Novel multi-component nanopharmaceuticals derived from poly(ethylene) glycol, retro-inverso-Tat nonapeptide and saquinavir demonstrate combined anti-HIV effectsExon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin TTranscriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir.The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 proteinTranscriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm.Potentiation of human immunodeficiency virus type 1 Tat by human cellular proteins.Intracellular expression of Tat alters mitochondrial functions in T cells: a potential mechanism to understand mitochondrial damage during HIV-1 replicationRecruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.Inhibition of human immunodeficiency virus type 1 Tat-dependent activation of translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires trans-activation response element loop sequencesPreventive effect of ascorbic acid against biological function of human immunodeficiency virus trans-activator of transcriptionIn vitro dynamics of HIV-1 BF intersubtype recombinants genomic regions involved in the regulation of gene expressionComparative functional analysis of Jembrana disease virus Tat protein on lentivirus long terminal repeat promoters: evidence for flexibility at its N-terminus.Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity.Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding.Murine CXCR-4 is a functional coreceptor for T-cell-tropic and dual-tropic strains of human immunodeficiency virus type 1.Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanismThe ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat.Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1.Functional differences between human and bovine immunodeficiency virus Tat transcription factors.
P2860
Q24314052-5026E1F3-9639-4D3B-9EB7-7A76FADC70B2Q24315725-42189F34-2EF7-49D3-BE59-05B57454DD2DQ24523183-EDB49715-8C7A-44B6-8E83-720625C9A6FDQ24527261-9730599A-E0E3-44FF-A568-10287FB86CB0Q24568329-D0F84178-C164-4098-A3F4-BC459601AA98Q24605935-69594415-72B8-45F4-B864-A15248701DFCQ24646774-CDD4ACE0-07AD-4D02-B92E-CCC7C3DEA9D5Q24675484-0DF52E6C-7A44-43E5-BD4C-177CE4EE5DA3Q24676286-AFEFAFD8-853F-43E8-93FA-292F188A468DQ24682531-A627A553-9D1A-473B-8F24-C745959E47FDQ24806541-72AB3EAE-F34A-43B4-95A0-3B13955A8393Q28116305-58A3BCE3-F2F2-4E92-8A0C-144FE3FF2DB9Q29614788-AF700562-AF9F-4FC3-AA10-E1E9FAC8D9C5Q29620167-2F3FE0A9-00B2-4D93-9F5A-5272FE2DD949Q33785137-E7E47967-61A8-4A76-80EA-5F9B769E79D3Q33850701-EC5FCD70-890A-4814-AD1D-D92762B8F358Q33930482-B52352D8-426B-4C54-96F3-3ABAB20ECFD5Q34361291-C5C318CA-00A7-468E-A148-B9C47D40074FQ34691351-533B1257-24AC-4142-809D-ADA71F98B5E6Q34888756-3315A480-726C-4166-B811-EF29F7969354Q34987620-59902200-CB3A-4A8D-8A59-1F51CEEC7166Q35155025-2E8528FC-CA5C-4B6C-839E-A6BA43A356FCQ35211232-8417BE70-7441-4284-AE39-536C8A22647BQ35782702-DC9A2018-0046-4789-B8BD-9FE11A5BF8AFQ35870516-FA45DE3C-9B71-4F55-9F12-DFFD535DAFBFQ35872597-ACA3913F-9BE7-4AE9-8A03-55B75EB355D4Q35893644-D2F725D9-BDFD-469D-8813-6CB83AEBBCE0Q36063046-57CAEB8E-403C-40D2-B3AC-3E712595DA2CQ36405698-CFADBC32-733A-43FE-B471-98EC4A7A51EBQ36618678-A92DDF13-BB13-4E15-858B-49ACE5D0149DQ36810917-7DC805FC-5380-4CCA-976E-97BEDEDDA43EQ37281360-B0D45047-BF61-4B50-B72D-9569620F875EQ37417688-9CA0FEB1-81C5-4E39-94EC-C44C92FFC8C0Q37633631-90DD5FDD-17D7-4E27-9DEE-E5B57EFBC4A6Q38296024-D13FFD3D-4E04-49B9-B153-3D773EA5AEEEQ38908741-C060769A-1AA2-4E9B-9330-A28372CDFA5EQ39446082-38A7CD18-2E22-464C-94C1-98163CD8AE8CQ39580108-CA954706-E2F2-4F1F-A3A3-032532E5C754Q39589026-CC1894AC-13BC-4982-A91C-EC6365B77609Q39591095-7DDDC7B5-6B8F-4BF3-95F5-21B1C8170766
P2860
Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Genetic analysis of the cofact ...... ncy virus type 1 Tat function.
@en
type
label
Genetic analysis of the cofact ...... ncy virus type 1 Tat function.
@en
prefLabel
Genetic analysis of the cofact ...... ncy virus type 1 Tat function.
@en
P2860
P1433
P1476
Genetic analysis of the cofact ...... ency virus type 1 Tat function
@en
P2093
P2860
P304
P407
P577
1993-07-01T00:00:00Z